* Appointment of chief medical officer
* appointed Michael Khan to oversee Phase II clinical trials
Wednesday 2 January 2013
BRIEF-Silence Therapeutics appoints chief medical officer
LONDON, Jan 2 (Reuters) - Silence Therapeutics PLC :
* Appointment of chief medical officer
* appointed Michael Khan to oversee Phase II clinical trials 
* Appointment of chief medical officer
* appointed Michael Khan to oversee Phase II clinical trials
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment